Tag: Research News
Shake It Up is proud to announce the funding of two innovative research projects aimed at deepening our understanding of Parkinson’s disease and adv...
Shake It Up Australia Foundation is excited to announce that a groundbreaking paper, led by The Michael J. Fox Foundation (MJFF) and international exp...
The Shake It Up Australia Foundation is proud to announce that its founder, Clyde Campbell AM, has been awarded the prestigious Peter Wills Medal by R...
In 2023, the Michael J. Fox Foundation for Parkinson’s Research (MJFF) announced an enormous leap forward in the understanding of Parkinson’s ...
Shake It Up is delighted to announce Dr. Gerard Tao as the first recipient of the Shake It Up Australia Movement Disorder Fellowship, with this first ...
By Claire E. O’Hanlon, Shannon D. Donofry, Cheryl Coon, David Dexter, Sonya Eremenco, Catherine Kopil, Helen Matthews, Vicki Miller, Diane Stephenso...
Shake It Up Australia and the National Parkinson’s Alliance welcomes the Federal Government’s announcement of $800,000 in funding over two years t...
April 11 is World Parkinson’s Day.
At Shake It Up, we believe that when our community comes together, we can make a world of difference.
This ti...
National Parkinson’s Alliance formed to lead change for Parkinson’s community.
Shake It Up Australia is pleased to announce the formation of the N...
Shake It Up recently announced funding for a new research project investigating quantitative mapping of aSyn soluble and insoluble PTMs in selected br...
An international team of patient, research and industry leaders, including Shake It Up Australia, have collaborated to propose the first iteration of ...
Over 200,000 Australians are currently living with Parkinson’s disease, with a further 38 diagnosed everyday. It’s the fastest growing neu...
We are rapidly approaching the end of 2023, a huge year in Parkinson’s research. Thank you to everyone in our community for your steadfast support o...
Earlier this month, Shake It Up was thrilled to announce funding for year 2 of the Australian Parkinson’s Genetics Study, led by Associate Pro...
Shake It Up was thrilled to announce funding for a new research project led by Dr Nicolas Dzamko, PhD, Senior Research Fellow, Brain and Mind Centre.Â...
Australia will soon have the capacity to host more in-depth and innovative clinical trials for Parkinson’s disease after funding was announced to de...
In this chat with Dr. Fazel Shabanpoor, we hear about his research into antisense oligonucleotides (ASOs), which offer a new therapeutic strategy in P...
In June this year, we shared the first of our regular quarterly progress updates for the Shake It Up Australia Foundation. Since then, we’ve seen ma...
200,000 Australians are currently living with Parkinson’s disease, with a further 38 diagnosed everyday. It’s the fastest growing neurological dis...
In this chat with Dr. Cedric Bardy, Associate Professor at SAHMRI (South Australia Health and Medical Research Institute) and Flinders University, we ...
In this chat with Associate Professor Miguel RenterÃa, we hear about the Australian Parkinson’s Genetics Study, and how the study of genes is h...
Last month, Shake It Up CEO Vicki Miller and Founder Clyde Campbell had the privilege of travelling to Barcelona to attend the 2023 World Parkinson Co...
Content originally published on the UNSW website.
A new app, co-designed by people with Parkinson’s disease, has been launched to help those living ...
On the heels of a big breakthrough — a spinal fluid (CSF) test for Parkinson’s, or alpha-synuclein seed amplification assay (α-syn SAA in CSF) â€...
In December of last year, I took on the role as CEO of Shake It Up Australia, after nearly six years as Executive General Manager. At the time, I shar...
Scientists from UNSW Sydney with collaborators at Boston University have developed a tool that shows early promise in detecting the onset of Parkinson...
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative ...
WEHI (The Walter and Eliza Hall Institute of Medical Research), is establishing a Parkinson’s Disease Research Centre of Excellence in collaborative...
Parkinson’s disease (PD) currently affects over 10 million people worldwide, and 200,000 Australians live with the disease, while another 38 are...
A new research study being conducted by Abbvie aims to understand how Parkinson’s disease is affecting people living with the condition, their f...
Parkinson’s disease (PD) isn’t the same for every patient. Patients will progress at different rates, or experience certain symptoms that affect t...
The U.S. Food and Drug Administration (FDA) last week approved lecanemab (brand name Leqembi) developed by Eisai Co Ltd. and Biogen Inc. for people w...
Another new medication for Parkinson’s may soon be on its way to the U.S. Food and Drug Administration (FDA) for possible approval.
Neuroderm recent...
BRAIN-PENETRATING ANTISENSE OLIGONUCLEOTIDE TO DOWN-REGULATE ALPHA-SYNUCLEIN
Antisense oligonucleotides (ASOs) offer a new therapeutic strategy in Par...
At the International Conference on Alzheimer’s & Parkinson’s Diseases (AD/PD), a research team funded by The Michael J. Fox Foundation is anno...
Researcher: Professor Paul Fisher
Research Institute: La Trobe University
Professor Fisher and his research team are investigating mitochondrial funct...
AÂ new study, funded by The Michael J. Fox Foundation, suggests that, among people with rheumatoid arthritis, use of the medications chloroquine and h...
Many people are curious how cannabis, including marijuana, may help Parkinson’s disease (PD) symptoms. While clinical trials have not yet proven saf...
A significant milestone in brain disease research was achieved early this week when the U.S. Food and Drug Administration (FDA) announced approval of...
People with Parkinson’s disease (PD) often ask about complementary medicine and alternative therapies that might work for different symptoms. Althou...
Study demonstrates the use of a wearable device in treatment of Parkinson’s disease resulted in significant improvement in patient outcomes compared...
New research published in the journal Brain suggests that people with diabetes who take the medication exenatide may have a lower risk of developing...
Star-shaped cells called astrocytes perform many duties in the brain, but their latest trick could replace dopamine cells lost in Parkinson’s diseas...
Last month Marco Baptista – Vice President of Research Programs for The Michael J. Fox Foundation joined more than 9,000 people from pharmaceuti...
A new study by Cedars-Sinai research suggests that if you were diagnosed with Parkinson’s before age 50, you might have been born with it.
The s...
A trial of great interest to the Parkinson’s community today reported top-line findings. The Nilotinib in Parkinson’s Disease (NILO-PD) study show...
Shake It Up are excited to announce three new Parkinson’s research projects which have been funded in collaboration with The Michael J. Fox Foun...
Parkinson’s research continues to advance at a rapid pace. Led by moderator Soania Mathur, MD, co-chair of The Michael J. Fox Foundation’s Patient...
A recent study in the journal Neurology reports that impulse control disorders (ICDs) — compulsive gambling, shopping or eating, or excessive intere...